KELSEYVILLE, CA, Feb. 16, 2018 -- Vet Online Supply, Inc. (OTC PINK: VTNL) (the Company), announces today a share buyback and dividend program for 2018.
Dan Rushford, CEO, stated, “Our recent purchase orders for January and February 2018 of $529,790 and $245,000 have allowed our Company to start the process to purchase-back shares of the company in order to focus on anti-dilution measures, stock price increases and minimizing the number of shareholders as we target the New York Stock Exchange listing procedures. We are designing a program to provide prorated dividends to our shareholders. Dividend stocks are inflation resistant because as prices rise the profits of a company rise as well. Dividends are based off company profits, and we want our shareholders to benefit and support Vet Online Supply. We are approaching our revenue target sooner than anticipated, and this will assist us in expediting our plan, according to management.”
The company received its first retail order from a major CBD retailer on December 13, 2017 for the purchase of 5,000 units of the CBD Pet Treats and CBD Pet Drops for approximately $245,000, and another purchase order of $529,790 for 10,000 units of our CBD Pet Drops and 7,000 units of our CBD Pet Supplement Treats.
The company will announce another new private label of its new Pet Performance Product in February 2018. Projected earnings for the Pet Performance Product in 2018 are $1.3M.
The company will announce another new breeding franchise in February 2018. Projected earnings for the breeding franchise in 2018 are $1.1M. The breeding franchise business model integrates the Pet Products on a national scale.
ABOUT VET ONLINE SUPPLY:
Vet Online Supply Inc. is a small US based online retail reseller of proprietary veterinary products. The goal of "Vet Online Supply" is to provide the $38B industry with value priced, superior quality products.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Contact: Meridian Consulting 323-364-3793


More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
FTC Questions Apple News Over Alleged Bias Against Conservative Media
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
How Marco Pharma International Preserves German Homeopathic Traditions in America 



